coronavirus antibody | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
January 31, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, JANUARY 31, 2023

coronavirus antibody

Representation Image. Photo: Reuters
Coronavirus chronicle

Children have stronger antibody response to Covid: Study

This is a key type of “neutralizing” antibody that binds to the spike protein of the virus, preventing it from invading cells

A scientist holds cells that produce antibodies against the coronavirus disease (Covid-19) under a microscope, in a university lab in Athens, Greece, July 8, 2020. Picture taken July 8, 2020/ Reuters
Coronavirus chronicle

Covid-19 antibody surveys underestimate infections: Study

Photo: Reuters 
Coronavirus chronicle

Preliminary results show Chinese Covid-19 vaccine candidate safe

Eli Lilly and Regeneron Pharmaceuticals Inc. are asking the US government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. Photo: AP
Coronavirus chronicle

Antibody drugs are no cure but seem promising for Covid-19

A scientist works in the lab of Linqi Zhang on research into novel coronavirus disease (Covid-19) antibodies for possible use in a drug at Tsinghua University's Research Center for Public Health in Beijing, China, March 30, 2020/ Reuters
Coronavirus chronicle

US warns of fraudulent coronavirus antibody tests

China begins human trial on another potential Covid-19 antibody therapy
Coronavirus chronicle

China begins human trial on another potential Covid-19 antibody therapy

Antibodies found in US Navy sailors on aircraft carrier: Study
Coronavirus chronicle

Antibodies found in US Navy sailors on aircraft carrier: Study

People get lunch and enjoy good weather at the Humlegarden park during the coronavirus disease (Covid-19) outbreak, in Stockholm, Sweden April 22, 2020. TT News Agency/Janerik Henriksson via Reuters
Coronavirus chronicle

1 in 5 in Stockholm have virus antibodies: Sweden

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]